No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon

Share this content:
No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon
No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon

FRIDAY, Dec. 30, 2016 (HealthDay News) -- For patients undergoing autologous breast reconstruction, the incidence of chronic postsurgical pain (CPSP) does not differ for patients receiving transversus abdominis plane (TAP) catheters delivering bupivacaine or saline bolus, according to a study published online Dec. 20 in Pain Practice.

Justin Oh, from the Toronto General Hospital, and colleagues conducted a prospective follow-up study to compare the incidence of CPSP after autologous breast reconstruction between patients who received postoperative intermittent TAP catheters with bupivacaine or saline boluses. Participants included 93 patients who underwent deep inferior epigastric artery perforator or muscle-sparing transverse rectus abdominis breast reconstruction and were randomly allocated to receive TAP catheters with bupivacaine or saline.

The researchers found that at six and 12 months after surgery, 24 and 23 percent of patients reported CPSP, respectively. Pain-related variables, including incidence of CPSP, did not differ between the groups. The likelihood of having CPSP was increased at six months, but not at 12 months, among patients who reported greater variability in pain scores at rest over the first 48 hours postoperatively.

"Neither postoperative use of bupivacaine vs. saline in the TAP catheters nor acute pain severity influenced the six- or 12-month incidence of CPSP," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Incidence of death or cardiac arrest 1.74 per 100,000 participants; higher incidence in men, with age

ACP Does Not Support Legalization of Assisted Suicide

ACP Does Not Support Legalization of Assisted Suicide

Legalization would affect trust in the patient-physician relationship, and in the medical profession

AAP: Epinephrine Admin Training Needed in Many Schools

AAP: Epinephrine Admin Training Needed in Many Schools

In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff

is free, fast, and customized just for you!

Already a member?

Sign In Now »